Clinical trials
Observational Spinal Cord Injuries trials in Turkey (Türkiye)
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 6 |
| 2024 | 3 |
| 2025 | 6 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ankara City Hospital Bilkent | 6 |
| Gaziler Physical Medicine and Rehabilitation Education and Research Hospital | 5 |
| Afyonkarahisar Health Sciences University | 3 |
| Istinye University | 3 |
| Gaziosmanpasa Research and Education Hospital | 2 |
| Istanbul Gelisim University | 2 |
| Istanbul Physical Medicine Rehabilitation Training and Research Hospital | 2 |
| Bandırma Onyedi Eylül University | 1 |
| Fatih Sultan Mehmet Training and Research Hospital | 1 |
| Gaziantep Islam Science and Technology University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Spinal Cord Injuries | 30 |
| Multiple Sclerosis | 2 |
| Urinary Bladder, Neurogenic | 2 |
| Infections | 1 |
| Muscle Spasticity | 1 |
| Musculoskeletal Pain | 1 |
| Osteoarthritis | 1 |
| Osteoporosis | 1 |
| Paraplegia | 1 |
| Quadriplegia | 1 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.